Rodolphe Barrangou, a genomic-editing expert at North Carolina State University who was not involved in the research, said ...

Instead of requiring personalized gene edits for each patient, the new approach could create a standardized method to use for ...

The inventor of base and prime editing shares insights on medicine's efforts to make serious genetic diseases treatable or ...

An experimental gene-editing treatment shows promise for permanently lowering levels of cholesterol and triglycerides, ...

A single multipurpose gene-editing tool can correct several genetic conditions by restoring proteins that have been truncated ...

In a highly anticipated article, FDA officials Vinay Prasad, M.D., and Martin Makary, M.D., outlined a novel regulatory ...

San Francisco-based startup Preventive has raised nearly $30 million from investors, including OpenAI CEO Sam Altman and ...

The global cell therapy market was valued at $5.88 billion in 2024 and is on track to hit $44.39 billion by 2034, expanding ...

The Global Gene Editing Market, valued at USD 4.68 billion in 2023, is poised for transformative growth, projected to expand at a compound annual growth rate (CAGR) of 10.2% through 2033. This dynamic ...

Moligo Technologies, a DNA synthesis company advancing gene therapies, announced today the publication of an article in Nature Communications that demonstrates enzymatically synthesized ...

CRISPR-based technology is advancing rapidly, driving international competition. Its promise to transform medicine is colliding with political and social realities, even as applications expand.

Genetic manipulation – or gene editing – is a concept that describes altering the genetic material (DNA) of an organism.